COVID-19 pandemic is now beyond control and needs easily translatable therapeutic solutions. Here, the possibilities of developing prophylactic antiviral formulations that can be interfaced with medical devices are discussed exploring novel molecular pathways and biomimetic engineering approaches.
Dr. Kaladhar Kamalasanan, “Biomimetic conjoining pathways for COVID-19 drug discovery, nanomedicine and medical devices: Prophylactic medicines as alternative for vaccines”, Trends in Biomaterials and Artificial Organs, vol. 34, no. 3, pp. 73-74, 2020.